The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
Johnson & Johnson reports interim results from a Phase 1/2 study of its SARS-CoV-2 vaccine in the New England Journal of Medicine, according to Bloomberg.
In Genome Research this week: transcriptome analysis of canine mammary tumors, collection of small RNAs found in disease-spreading mosquitoes, and more.
The Washington Post reports there is no evidence that the rise in COVID-19 cases in the US is due to a particular strain, but notes scientists' ability to detect variants is limited.
A lack of a national SARS-CoV-2 genome sequencing strategy is hindering the ability of the US to track and uncover emerging SARS-CoV-2 strains, according to the New York Times.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.